[Informative value of radiodiagnosis methods of pyelo-ureteral strictures in kidney anomaly].

A total of 98 patients aged 18-67 years (mean age 42.5 +/- 10.3 years) suspected to have a pelviureteral stricture (PUS) were examined using ultrasound investigation in B-mode (BUI), excretory urography (EU), angiography, slice and multislice computed tomography (SCT, MSCT). This combined examination allowed to make diagnosis of hydronephrosis in 83 (84.7%) patients including PUS diagnosis in 48 (57.8%) patients. Basing on CT findings PUS was operated in 41 (85.4%) patients. Sensitivity, specificity and accuracy of BUI in detection of the level of the upper urinary tract obstruction was 92.8, 75.0, 89.3%, EU--94.5, 77.8, 92.2, SCT--100, 97, 98.1%, respectively. MSCT detected the level of the obstruction in all the cases. PUS was identified by BUI in 26.5, 89.3, 65.6, EU--in 81.3, 73.7, 79.1, by SCT in 90.5, 96.8, 94.2, MSCT--96.3, 100, 97.8% cases. Thus, MSCT is most effective in radiodiagnosis of PUS and can be recommended as a method of choice in PUS.

[Using setegis (terasosine) in early postoperative period after transurethral prostate resection].

TUR of the prostatic gland for prostatic adenoma was made in 93 patients aged 54-81 years (mean age 64.4 +/- 7.5 years). The patients were divided into two groups. Patients of group 1 (n = 31) received no alpha-adrenoblockers, those of group 2 (n = 62) received terasosine in pre- and postoperative period. Group 2 patients demonstrated significant improvement in clinical parameters, postoperative hospital stay for them decreased by 11.3%, side effects were insignificant, their residual urine early after operation was 26.3 +/- 8.6 cm3 while 4 weeks after TUR it was 16.3 +/- 6.9 cm3. Thus, terasosine (setegis) can be recommended for use in early postoperative period after TUR of the prostate for prostatic adenoma as an effective and safe drug improving postoperative outcome.

[Results of transcutaneous nephrolithotripsy using the combined lithotriptor "2 in 1" "Swiss Lithoclast Master"]. / Rezul'taty chreskozhnoi nefrolitotripsii na kombinirovannom litotriptore "2 v 1" "Swiss Lithoclast Master".

The aim of the study was to determine frequency of infectious-inflammatory complications regarding the duration of transcutaneous nephrolithotripsy (TCNL). Two groups of nephrolithiasis patients were compared. Group 1 consisted of 37 nephrolithiasis patients aged 20 to 78 years (15 males, 22 females). Size of the concrements ranged from 1.8 to 4.9 cm. They underwent contact lithotripsy performed by an ultrasound lithotriptor. Group 2 consisted of 22 patients aged 34 to 74 years (11 males and 11 females). Nephroliths were 2.0 to 8.5 cm in size. Group 2 patients underwent combined contact pneumatic and ultrasound lithotripsy on a novel Swiss LithoClast Master unit. Elimination of the nephroliths was observed in 27 (72.9%) patients of group 2 and in 19 (86.3%) patients of group 2. Residual calculi were detected in 10 (27%) patients of group 1. Surgery lasted 66 to 140 min (mean 81.2) and 40 to 120 min (mean 58.5 min) in groups 1 and 2, respectively. Pyelonephritis activity was registered in 24 (77.4%) and 3 (13.6%) patients, respectively. Thus, in percutaneous lithotripsy of large stones, frequency of inflammatory complications depends not only on technical faults and initial bacteriuria, but also on the duration of the operation. If surgical intervention took more than 60 min, frequency of the infectious-inflammatory complications increased 1.6-fold. Utilization of the lithotriptor Swiss LithoClast Master raises efficiency, accelerates destruction and evacuation of stones.